William Blair & Company’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$306K Buy
2025
Q1
$342K Buy
2024
Q4
$439K Buy
2024
Q3
$164K Buy
2024
Q2
$141K Buy
2024
Q1
$165K Buy
2023
Q4
$76.5K Buy
2023
Q3
$82.5K Buy
2023
Q2
$209K Buy
2023
Q1
$181K Buy
2022
Q4
$115K Buy
2022
Q3
$163K Buy
2022
Q2
$19K Buy